IL40685A - Pharmaceutical compositions for the dissolution of renal calculi containing magnesium and citrate ions and their preparation - Google Patents

Pharmaceutical compositions for the dissolution of renal calculi containing magnesium and citrate ions and their preparation

Info

Publication number
IL40685A
IL40685A IL40685A IL4068572A IL40685A IL 40685 A IL40685 A IL 40685A IL 40685 A IL40685 A IL 40685A IL 4068572 A IL4068572 A IL 4068572A IL 40685 A IL40685 A IL 40685A
Authority
IL
Israel
Prior art keywords
composition according
citrate
weight
ion source
magnesium
Prior art date
Application number
IL40685A
Other languages
English (en)
Other versions
IL40685A0 (en
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL40685A0 publication Critical patent/IL40685A0/xx
Publication of IL40685A publication Critical patent/IL40685A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL40685A 1971-11-08 1972-10-27 Pharmaceutical compositions for the dissolution of renal calculi containing magnesium and citrate ions and their preparation IL40685A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1185A HU165181B (ja) 1971-11-08 1971-11-08

Publications (2)

Publication Number Publication Date
IL40685A0 IL40685A0 (en) 1972-12-29
IL40685A true IL40685A (en) 1976-08-31

Family

ID=10994422

Family Applications (1)

Application Number Title Priority Date Filing Date
IL40685A IL40685A (en) 1971-11-08 1972-10-27 Pharmaceutical compositions for the dissolution of renal calculi containing magnesium and citrate ions and their preparation

Country Status (9)

Country Link
AT (1) AT332531B (ja)
CA (1) CA978479A (ja)
CS (1) CS217603B1 (ja)
DD (1) DD100631A1 (ja)
DE (1) DE2252665A1 (ja)
GB (1) GB1403900A (ja)
HU (1) HU165181B (ja)
IL (1) IL40685A (ja)
SU (1) SU1009467A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2826642C2 (de) 1978-06-19 1987-04-23 Dr. Madaus & Co, 5000 Köln Orales Urolithiasismittel
DE3046580A1 (de) * 1980-12-11 1982-07-01 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
DE3728814A1 (de) * 1987-08-28 1989-03-30 Lentia Gmbh Loesung zur anwendung als spuelfluessigkeit in der zerstoerung von koerperfremden ablagerungen in menschlichen und tierischen geweben oder koerperhohlraeumen
JP2545479B2 (ja) * 1989-02-07 1996-10-16 ミッション ファーマカル カンパニー，インコーポレーテッド 医薬組成物
CA1326040C (en) * 1989-11-16 1994-01-11 Neill B. Walsdorf Magnesium-potassium citrate
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
US8603989B2 (en) 2008-05-22 2013-12-10 Bristol-Myers Squibb Company Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same
FR2967576B1 (fr) 2010-11-18 2013-07-12 Advicenne Pharma Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
FR2967578B1 (fr) 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
MX352660B (es) * 2013-03-15 2017-12-04 Univ New York Bebida con contenido de citrato.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
FR2019261A1 (en) * 1969-03-19 1970-07-03 Melon Jean Marie Treatment of oxalic lithiase with succinic - acid and its derivs

Also Published As

Publication number Publication date
DD100631A1 (ja) 1973-10-05
AT332531B (de) 1976-10-11
GB1403900A (en) 1975-08-28
DE2252665C2 (ja) 1987-09-10
SU1009467A1 (ru) 1983-04-07
DE2252665A1 (de) 1973-05-10
IL40685A0 (en) 1972-12-29
CS217603B1 (en) 1983-01-28
CA978479A (en) 1975-11-25
ATA925372A (de) 1976-01-15
HU165181B (ja) 1974-07-27

Similar Documents

Publication Publication Date Title
IL40685A (en) Pharmaceutical compositions for the dissolution of renal calculi containing magnesium and citrate ions and their preparation
GB1131007A (en) Improvements in or relating to aqueous solutions of oxytetracycline
GB1518364A (en) Pharmaceutical composition
US4016090A (en) Stable bleaching composition
IE43901L (en) Pharmaceutical compositions
US2918400A (en) Sanitizing compositions
US5010069A (en) Stable liquid form of 5-aminosalicylic acid
GB1226394A (ja)
JPS5241613A (en) Granular or powdered detergent compositions
GB1256968A (ja)
GB1500408A (en) Process for the preparation of catalysts and supported catalysts
ES359336A1 (es) Procedimiento para la obtencion de una composicion a base de sulfato de estrona.
GB1221038A (en) Improvements in effervescent tablet compositions
GB1505738A (en) Tabletting processes
JPS5569515A (en) Pharmaceutical composition
GB1451352A (en) Method of suppressing mildew using a composition containing an alkanoic acid salt
US5006516A (en) Method for the prophylaxis of cardiac infarctions and the prevention of reinfarctions
CH651207A5 (fr) Composition pharmaceutique pour combattre l'agregation plaquettaire.
GB1361779A (en) Vincamine salt and its use as a pharmaceutical composition
GB829686A (en) Submerged arc welding flux composition
GB1219300A (en) Improvements in or relating to the preparation of an iron melt having a low sulphur content
GB1437788A (en) Therapeutic compositions
Rostoker et al. Fast freezing by atomization for aluminum alloy development
ES400335A1 (es) Un metodo para la preparacion de una composicion de polvo humedecible de un complejo halogenado de dihaluro cuaterna- rio.
GB1509778A (en) Pharmaceutical composition and dosage units thereof